Edition:
United States

Medical Equipment, Supplies & Distribution

Page 3

Shanghai Conant Macroflag Group sees 9-month net profit up 311.5-334.6 pct

Monday, 16 Oct 2017 12:36am EDT

Oct 16(Reuters) - Shanghai Conant Macroflag Group Co Ltd <300061.SZ> ::Says it expects 9-month net profit to rise 311.5-334.6 percent y/y, or to be 178 million yuan to 188 million yuan, from 43.3 million yuan year ago.

Jiangxi Sanxin Medtec sees Q1 to Q3 of FY 2017 net profit could rise up to 5 pct

Sunday, 15 Oct 2017 11:33pm EDT

Oct 16(Reuters) - Jiangxi Sanxin Medtec Co Ltd <300453.SZ>:Sees Q1 to Q3 of FY 2017 net profit could rise up to 5 percent, or to be 31 million yuan to 32.5 million yuan .Says Q1 to Q3 of FY 2016 net profit was 31 million yuan .

Tellgen sees Q1~Q3 FY 2017 net profit up 15 pct to 35 pct

Friday, 13 Oct 2017 10:28pm EDT

Oct 14(Reuters) - Tellgen Corp <300642.SZ> ::Sees Q1~Q3 FY 2017 net profit to increase by 15 percent to 35 percent, or to be 71.4 million yuan to 83.8 million yuan.Says Q1~Q3 FY 2016 net profit was 62.1 million yuan.The reason for the forecast is good industry development trend.

Visiomed H1 operating loss narrows to 5.5 million euros

Friday, 13 Oct 2017 12:18pm EDT

Oct 13 (Reuters) - VISIOMED GROUP SA ::H1 NET LOSS EUR 7.1 MILLION VERSUS EUR 5.6 MILLION YEAR AGO‍​.H1 OPERATING LOSS OF EUR 5.5‍​ MILLION VERSUS LOSS OF EUR 6.9 MILLION YEAR AGO.H1 REVENUE EUR ‍​5.1 MILLION VERSUS EUR 4.8 MILLION YEAR AGO.AIMS FOR OVER 50 PERCENT GROWTH IN H2.AIMS FOR GROWTH OF SALES AT OVER 30 PERCENT FOR FY‍​.

Guangzhou Improve Medical Instruments sees Q1 to Q3 FY 2017 net profit down 10 pct to 40 pct

Friday, 13 Oct 2017 07:59am EDT

Oct 13(Reuters) - Guangzhou Improve Medical Instruments Co Ltd <300030.SZ>:Sees Q1 to Q3 FY 2017 net profit to decrease by 10 percent to 40 percent, or to be 12.9 million yuan to 19.4 million yuan .Says Q1 to Q3 FY 2016 net profit was 21.5 million yuan .

Jafron Biomedical sees Q1 to Q3 FY 2017 net profit up 45 pct to 53 pct

Friday, 13 Oct 2017 07:13am EDT

Oct 13(Reuters) - Jafron Biomedical Co Ltd <300529.SZ>:Sees Q1 to Q3 FY 2017 net profit to increase by 45 percent to 53 percent, or to be 201.9 million yuan to 213 million yuan .Says Q1 to Q3 FY 2016 net profit was 139.2 million yuan .Says that increased sales as the main reason for the forecast .

Tandem Diabetes Care sees Q3 sales of about $26.5 mln to $27.5 mln

Friday, 13 Oct 2017 06:27am EDT

Oct 13 (Reuters) - Tandem Diabetes Care Inc ::Sees Q3 sales about $26.5 million to $27.5 million - sec filing.Tandem Diabetes - expect seasonality to have similar impact on sales in 2017.Tandem - ‍do not expect funding from completed or proposed financing to fully address substantial doubt about co's ability to continue as a going concern​.Tandem Diabetes-expectation of seasonality impact excludes about $3.5 million deferred sales&upgrade fees received with technology program expected in q3​.Tandem Diabetes Care Inc- ‍expect we will be required to raise additional capital in order to continue as a going concern​.

Shandong Intco Medical Products sees Q1 to Q3 of FY 2017 net profit up 70 pct to 80 pct

Friday, 13 Oct 2017 04:35am EDT

Oct 13(Reuters) - Shandong Intco Medical Products Co Ltd <300677.SZ>:Sees Q1 to Q3 of FY 2017 net profit to increase by 70 percent to 80 percent, or to be 109 million yuan to 115.4 million yuan .Says Q1 to Q3 of FY 2016 net profit was 64.1 million yuan .Says increased capacity and sales volume is the main reason for the forecast.

Top glove Corp enters term sheet for proposed acquisition of Eastern Press

Friday, 13 Oct 2017 01:41am EDT

Oct 13 (Reuters) - Top Glove Corporation Bhd ::Enters term sheet with Y.S. Hoong for proposed acquisition of Eastern Press for indicative consideration of 47.25 million RGT.

Top Glove Corp says qtrly net profit 98.6 mln rgt​

Friday, 13 Oct 2017 01:36am EDT

Oct 13 (Reuters) - Top Glove Corporation Bhd ::Qtrly net profit 98.6 million rgt and qtrly revenue ‍902.4 million rgt ​.Year ago qtrly revenue 722.1 million rgt, year ago qtrly profit attributbale 65.3 million rgt‍​.Recommends single tier final dividend of 8.5 sen per share for FY ended 31 August 2017.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary